BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8959655)

  • 1. Prognosis for canine malignant mammary tumors based on TNM and histologic classification.
    Yamagami T; Kobayashi T; Takahashi K; Sugiyama M
    J Vet Med Sci; 1996 Nov; 58(11):1079-83. PubMed ID: 8959655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
    Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
    Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles.
    Benjamin SA; Lee AC; Saunders WJ
    Vet Pathol; 1999 Sep; 36(5):423-36. PubMed ID: 10490210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and grading of canine mammary tumors.
    Goldschmidt M; Peña L; Rasotto R; Zappulli V
    Vet Pathol; 2011 Jan; 48(1):117-31. PubMed ID: 21266722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.
    Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M
    Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
    de Araújo MR; Campos LC; Ferreira E; Cassali GD
    J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of a new histological and molecular-based classification of canine mammary neoplasia.
    Im KS; Kim NH; Lim HY; Kim HW; Shin JI; Sur JH
    Vet Pathol; 2014 May; 51(3):549-59. PubMed ID: 24003019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of those histopathologic parameters predictive of invasion of the lymphatic system by canine mammary carcinomas.
    Rasotto R; Zappulli V; Castagnaro M; Goldschmidt MH
    Vet Pathol; 2012 Mar; 49(2):330-40. PubMed ID: 21670194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
    Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
    J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method.
    Karayannopoulou M; Kaldrymidou E; Constantinidis TC; Dessiris A
    J Comp Pathol; 2005 Nov; 133(4):246-52. PubMed ID: 16202421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors.
    Sarli G; Preziosi R; Benazzi C; Castellani G; Marcato PS
    J Vet Diagn Invest; 2002 Jan; 14(1):25-34. PubMed ID: 12680640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002).
    Chang SC; Chang CC; Chang TJ; Wong ML
    J Am Vet Med Assoc; 2005 Nov; 227(10):1625-9. PubMed ID: 16313041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
    Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
    Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
    Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
    Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic value of c-met in canine mammary tumours.
    Chen YC; Chen YY; Liao JW; Chang SC
    Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological prognostic factors in canine mammary tumors.
    Pérez Alenza MD; Peña L; Nieto AI; Castaño M
    Ann Ist Super Sanita; 1997; 33(4):581-5. PubMed ID: 9616968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of regional lymph node status in canine mammary carcinomas.
    Szczubiał M; Łopuszynski W
    Vet Comp Oncol; 2011 Dec; 9(4):296-303. PubMed ID: 22077411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
    Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
    Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of host factors on survival in dogs with malignant mammary gland tumors.
    Philibert JC; Snyder PW; Glickman N; Glickman LT; Knapp DW; Waters DJ
    J Vet Intern Med; 2003; 17(1):102-6. PubMed ID: 12564734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.